Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells
- 18 May 2006
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 236 (2) , 250-258
- https://doi.org/10.1016/j.canlet.2005.05.017
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cellsJournal of Endocrinology, 2004
- Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cellsJournal of Cellular Biochemistry, 2004
- Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: Inhibition of proliferation and induction of apoptosisLife Sciences, 2002
- Arsenic trioxide induces apoptosis in human gastric cancer cells through up‐regulation of P53 and activation of caspase‐3International Journal of Cancer, 2000
- Arsenic Trioxide Inhibits Neuroblastoma Growth in Vivo and Promotes Apoptotic Cell Death in VitroBiochemical and Biophysical Research Communications, 2000
- Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia PatientsBlood, 1999
- Effect of Arsenic Trioxide on Cell Cycle Arrest in Head and Neck Cancer Cell Line PCI-1Biochemical and Biophysical Research Communications, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR Independent MannerBlood, 1998
- Ancient Remedy Performs New TricksScience, 1996